All Insights

Managing Covid-19

Coronavirus Legal Briefing | The activist state

Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times. In this edition

Commercial

Government guidance on responsible contractual behaviour

Overview and analysis of the new guidance from The Cabinet Office and the Infrastructure and Projects Authority

Life Sciences and Healthcare

Telemedicine on the rise in Europe

The European telemedicine industry is on the rise as a result of recent legalisation of activities such as remote treatment

Life Sciences and Healthcare

CJEU clarifies conditions for obtaining SPC protection for medicinal products

Royalty Pharma: the CJEU's latest decision on Supplementary Protection Certificates addresses when medicinal products can be "protected by a basic

Corporate

Proposal to amend the Good Governance Code of Listed Companies

The Spanish National Securities Market Commission (the "CNMV") is expected to approve, at the end of the first semester of

Managing Covid-19

Coronavirus Legal Briefing | The latest on the UK government's funding schemes for business

Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.

Managing Covid-19

Coronavirus Legal Briefing | The EU's exit strategy for business

Welcome to Osborne Clarke's Coronavirus Legal Briefing, our newsletter on business law issues in these sombre times.

Life Sciences and Healthcare

State aid | Part III – European Commission amends Temporary Framework to include aid for Life Sciences sector

Life sciences businesses working on Covid-19 related products may be able to benefit from government funding for a range of

Life Sciences and Healthcare

Diversifying into Covid-19 protection products : relaxation of the regulatory regime

In light of the impact of Covid-19 on businesses and the critical need for additional supplies for frontline staff and